UPDATED Apr 23, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A211050 | ₩4,900.00 | 0% | 140.0% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
CAI | AU$0.13 | 8.3% | -36.6% | AU$98.9m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
300286 | CN¥18.70 | 2.9% | -46.5% | CN¥4.0b | CN¥30.92 | PE19.6x | E24.3% | 1.6% | Capital Goods | ||
NEWBRY | kr3.39 | -3.1% | -39.0% | kr82.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
A036200 | ₩10,400.00 | -11.1% | 35.9% | ₩310.8b | ₩13,000.00 | PE17x | E39.8% | 0.8% | Semiconductors | ||
A178320 | ₩25,300.00 | 7.9% | 56.2% | ₩938.9b | ₩31,000.00 | PS1.2x | E89.6% | 0.6% | Tech | ||
688711 | CN¥26.26 | 1.9% | -60.1% | CN¥4.0b | n/a | PE34.8x | E49.6% | 0.05% | Semiconductors | ||
HHR | AU$0.007 | -12.5% | -79.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
CALTX | kr100.40 | -0.5% | -18.7% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$3.99 | -6.8% | 62.2% | US$218.7m | US$8.50 | PS2.5x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.56 | -1.7% | -12.0% | US$191.7m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$13.98 | 1.2% | -36.7% | US$2.2b | US$29.75 | PE170.5x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.57 | -8.6% | -39.2% | US$231.7m | US$26.06 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$143.80 | -1.0% | -27.2% | US$18.5b | US$220.00 | PS9.9x | E60.6% | n/a | Pharmaceuticals & Biotech | ||
FTCI | US$0.42 | 2.4% | -83.8% | US$52.3m | n/a | PB0.8x | E63.1% | n/a | Capital Goods | ||
SEAPT | kr4.94 | -1.2% | -61.7% | kr1.8b | kr11.57 | PB1x | E54.2% | n/a | Energy | ||
300442 | CN¥30.03 | -2.2% | -16.4% | CN¥51.7b | CN¥35.52 | PE29.3x | E28.4% | 1.7% | Software | ||
FXPO | UK£0.52 | 12.9% | -53.1% | UK£307.1m | UK£1.41 | PB0.3x | E116.3% | 0% | Materials | ||
4071 | ر.س219.40 | -2.1% | 76.9% | ر.س10.9b | ر.س275.17 | PE34.2x | E27.1% | 1.0% | Media | ||
CLBIO | kr10.40 | -5.5% | -7.6% | kr223.5m | kr32.00 | PS6.3x | E71.1% | n/a | Pharmaceuticals & Biotech | ||
688390 | CN¥92.01 | -11.1% | -56.5% | CN¥15.9b | CN¥133.61 | PE18.3x | E27.1% | 1.2% | Capital Goods | ||
KCB | KSh30.00 | 11.1% | -11.8% | KSh95.8b | KSh51.24 | PB0.4x | E26.0% | 0% | Banks | ||
SONM | US$0.48 | -9.0% | -59.4% | US$20.6m | US$2.00 | PB0.9x | E139.9% | n/a | Tech | ||
DIGN | kr1.67 | -7.2% | -61.8% | kr117.7m | kr9.50 | PS1.4x | E139.0% | n/a | Healthcare |